Nano Revolution in Cardiovascular Health: Nanoparticles (NPs) as Tiny Titans for Diagnosis and Therapeutics

J Abid, FMA Khalil, S Saeed, SU Khan, I Iqbal… - Current Problems in …, 2024 - Elsevier
… This review examines the effectiveness of nanoparticle diagnostic approaches for the early
diagnosis and monitoring of various cardiovascular illnesses. Additionally, weaim to evaluate …

Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases

I Arshad, A Kanwal, I Zafar, A Unar, M Hanane… - Environmental …, 2023 - Elsevier
… In cardiovascular health, NPs have gained significant interest as multifunctional instruments
due to their distinct physicochemical properties and adaptability. Several researchers (Ali et …

Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives

W Poller, S Dimmeler, S Heymans, T Zeller… - European heart …, 2018 - academic.oup.com
… We provide an update on recent developments and perspectives for diagnostic and therapeutic
use of ncRNAs in cardiovascular diseases, including atherosclerosis/coronary disease, …

RNA-based diagnostic and therapeutic strategies for cardiovascular disease

D Lu, T Thum - Nature Reviews Cardiology, 2019 - nature.com
… RNAs in the context of cardiovascular disease. Finally, we … /inhibitors for the treatment of
cardiovascular diseases. Given that … RNA diagnostic and therapeutic targets for cardiovascular

From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010–2020

JC Kovacic, V Fuster - Clinical Pharmacology & Therapeutics, 2011 - Wiley Online Library
… A vital aspect of the shift in focus to cardiovascular health and away from complex CAD/CVD
(… therapeutic transition to cardiovascular health is something we should all strive to achieve. …

The future of cardiovascular therapeutics

CA MacRae, DM Roden, J Loscalzo - Circulation, 2016 - Am Heart Assoc
… Despite this ongoing public health problem, drug development pipelines for cardiovascular
… landscape in cardiovascular drug development, and highlight therapeutic opportunities that …

Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases

GG Schiattarella, A Sannino, G Esposito… - Trends in cardiovascular …, 2019 - Elsevier
… Finally, we will discuss the modulation of gut microbiota for diagnostic and therapeutic
dyslipidemia will significantly impact on cardiovascular health management. A crosstalk between …

Diagnostic strategies for early recognition of cancer therapeutics–related cardiac dysfunction

CR Manrique, M Park, N Tiwari… - Clinical Medicine …, 2017 - journals.sagepub.com
cardiovascular dysfunction (CTRCD). This review article will focus on the early diagnosis
of … Currently, the identification of cardiac toxicity associated with cancer treatment is the …

miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204

Y Yang, T Yu, S Jiang, Y Zhang, M Li… - … on therapeutic …, 2017 - Taylor & Francis
… In this review, we discuss the basic research and clinical use of miRNAs as the early
diagnosis and therapeutic targets for CVD. We have also focused on the efficiency of …

[HTML][HTML] A Brief Review on Recent Advances in Diagnostic and Therapeutic Applications of Extracellular Vesicles in Cardiovascular Disease

D Das, G Jothimani, A Banerjee, A Dey… - … International Journal of …, 2024 - Elsevier
… for disease diagnosis and prognosis while also offering therapeutic potential through … in
cardiovascular health and disease, their potential in CVD diagnostics and therapeutics has yet to …